1. Home
  2. LPCN vs OST Comparison

LPCN vs OST Comparison

Compare LPCN & OST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • OST
  • Stock Information
  • Founded
  • LPCN 1997
  • OST 2010
  • Country
  • LPCN United States
  • OST China
  • Employees
  • LPCN N/A
  • OST N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • OST Industrial Machinery/Components
  • Sector
  • LPCN Health Care
  • OST Technology
  • Exchange
  • LPCN Nasdaq
  • OST Nasdaq
  • Market Cap
  • LPCN 16.1M
  • OST 15.7M
  • IPO Year
  • LPCN N/A
  • OST 2022
  • Fundamental
  • Price
  • LPCN $2.95
  • OST $1.80
  • Analyst Decision
  • LPCN Strong Buy
  • OST
  • Analyst Count
  • LPCN 2
  • OST 0
  • Target Price
  • LPCN $9.00
  • OST N/A
  • AVG Volume (30 Days)
  • LPCN 36.3K
  • OST 380.9K
  • Earning Date
  • LPCN 08-05-2025
  • OST 08-25-2025
  • Dividend Yield
  • LPCN N/A
  • OST N/A
  • EPS Growth
  • LPCN N/A
  • OST N/A
  • EPS
  • LPCN N/A
  • OST N/A
  • Revenue
  • LPCN $4,208,119.00
  • OST $38,333,251.00
  • Revenue This Year
  • LPCN N/A
  • OST N/A
  • Revenue Next Year
  • LPCN N/A
  • OST N/A
  • P/E Ratio
  • LPCN N/A
  • OST N/A
  • Revenue Growth
  • LPCN N/A
  • OST 0.34
  • 52 Week Low
  • LPCN $2.68
  • OST $1.35
  • 52 Week High
  • LPCN $6.17
  • OST $235.00
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 37.54
  • OST 25.55
  • Support Level
  • LPCN $2.92
  • OST $1.35
  • Resistance Level
  • LPCN $3.25
  • OST $2.15
  • Average True Range (ATR)
  • LPCN 0.19
  • OST 0.33
  • MACD
  • LPCN -0.04
  • OST 4.26
  • Stochastic Oscillator
  • LPCN 4.41
  • OST 24.32

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About OST Ostin Technology Group Co. Ltd.

Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.

Share on Social Networks: